CRISPR/Cas9-mediated


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
03 2020
Historique:
received: 14 03 2019
accepted: 21 06 2019
pubmed: 30 6 2019
medline: 28 4 2021
entrez: 29 6 2019
Statut: ppublish

Résumé

A Autosomal-dominant

Identifiants

pubmed: 31248972
pii: haematol.2019.221804
doi: 10.3324/haematol.2019.221804
pmc: PMC7049355
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

598-609

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL151629
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI049393
Pays : United States

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Br J Haematol. 2010 Jul;150(2):196-9
pubmed: 20456363
J Thromb Haemost. 2016 Mar;14(3):551-8
pubmed: 26712312
Nat Med. 2006 Oct;12(10):1191-7
pubmed: 17063141
Br J Haematol. 2005 Apr;129(2):275-8
pubmed: 15813856
Nat Biotechnol. 2018 Sep;36(8):765-771
pubmed: 30010673
Hematol Oncol Clin North Am. 2013 Feb;27(1):75-88, viii
pubmed: 23351989
Nat Med. 1998 May;4(5):615-8
pubmed: 9585238
Blood. 2011 Mar 31;117(13):3539-47
pubmed: 21285438
Nat Med. 2009 Feb;15(2):151-8
pubmed: 19182797
Blood. 2014 Jan 23;123(4):562-9
pubmed: 24184683
Exp Hematol. 2019 Mar;71:51-60
pubmed: 30615903
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Blood. 1996 Sep 15;88(6):1907-29
pubmed: 8822908
Blood. 2007 Dec 15;110(13):4179-87
pubmed: 17761833
Br J Haematol. 2016 Jan;172(2):219-27
pubmed: 26567890
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10661-5
pubmed: 27601644
Blood. 2002 Jul 15;100(2):707-9
pubmed: 12091371
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
J Immunol. 2015 Sep 1;195(5):2177-86
pubmed: 26188059
Curr Opin Hematol. 2015 Jan;22(1):3-11
pubmed: 25427142
J Leukoc Biol. 2002 May;71(5):821-8
pubmed: 11994507
Br J Haematol. 2002 Sep;118(3):923; author reply 923-4
pubmed: 12181069
J Leukoc Biol. 2017 Oct;102(4):1143-1151
pubmed: 28754797
Ann N Y Acad Sci. 2009 Sep;1176:94-100
pubmed: 19796237
J Immunol. 2004 Dec 15;173(12):7277-81
pubmed: 15585850
Am J Respir Cell Mol Biol. 2004 Apr;30(4):576-84
pubmed: 14565940
Ann N Y Acad Sci. 2007 Jun;1106:143-51
pubmed: 17360796
Curr Opin Hematol. 2007 Jan;14(1):22-8
pubmed: 17133096
J Clin Invest. 2015 Aug 3;125(8):3103-16
pubmed: 26193632
Stem Cells Dev. 2016 Feb 15;25(4):360-5
pubmed: 26650921
F1000Res. 2018 May 15;7:594
pubmed: 29946444
Nat Med. 2012 Oct;18(10):1550-9
pubmed: 23001182
Nat Med. 2016 Sep;22(9):987-90
pubmed: 27525524
Blood Adv. 2019 Jan 8;3(1):63-71
pubmed: 30622144
Stem Cell Reports. 2015 Feb 10;4(2):282-96
pubmed: 25680479
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Blood. 2000 Oct 1;96(7):2317-22
pubmed: 11001877
J Immunol. 2004 Apr 1;172(7):4493-502
pubmed: 15034066
Nat Rev Dis Primers. 2017 Jun 08;3:17032
pubmed: 28593997
Blood. 2006 Jul 15;108(2):493-500
pubmed: 16551967
PLoS One. 2015 Apr 24;10(4):e0124633
pubmed: 25909470

Auteurs

Masoud Nasri (M)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Malte Ritter (M)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Perihan Mir (P)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Benjamin Dannenmann (B)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Narges Aghaallaei (N)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Diana Amend (D)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Vahagn Makaryan (V)

Department of Medicine, University of Washington, Seattle, WA, USA.

Yun Xu (Y)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Breanna Fletcher (B)

Department of Medicine, University of Washington, Seattle, WA, USA.

Regine Bernhard (R)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Ingeborg Steiert (I)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Karin Hahnel (K)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Jürgen Berger (J)

Max Planck Institute for Developmental Biology, Tübingen, Germany.

Iris Koch (I)

Max Planck Institute for Developmental Biology, Tübingen, Germany.

Brigitte Sailer (B)

Max Planck Institute for Developmental Biology, Tübingen, Germany.

Katharina Hipp (K)

Max Planck Institute for Developmental Biology, Tübingen, Germany.

Cornelia Zeidler (C)

Department of Oncology, Hematology, Immunology and Bone Marrow Transplantation, Hannover Medical School, Hannover, Germany.

Maksim Klimiankou (M)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

Baubak Bajoghli (B)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.

David C Dale (DC)

Department of Medicine, University of Washington, Seattle, WA, USA.

Karl Welte (K)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany.
University Children's Hospital Tübingen, Tübingen, Germany.

Julia Skokowa (J)

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany Julia.Skokowa@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH